Get my own profile
Public access
View all7 articles
5 articles
available
not available
Based on funding mandates
Co-authors
- Thomas H KellerInvestment Partner, Trinity Innovation Bioventures SingaporeVerified email at trinity-fund.com
- Jeffrey HillInstitute of Chemical Biology, Shenzhen Bay LaboratoriesVerified email at szbl.ac.cn
- Zhiyuan KeExperimental Therapeutics Centre, SingaporeVerified email at eddc.a-star.edu.sg
- David M. VirshupDuke-NUS Medical School SingaporeVerified email at duke-nus.edu.sg
- Babita MadanDuke-NUS Medical SchoolVerified email at duke-nus.edu.sg
- Anders PoulsenExperimental Therapeutic CentreVerified email at etc.a-star.edu.sg
- Alex MatterCEO, AtumRa Therapeutics Pte Ltd., SingaporeVerified email at atumratx.com
- Ralf AltmeyerMedusa TherapeuticsVerified email at medusa-therapeutics.com
- Meng Ling ChoongDrug Discovery Scientific Project Lead, APACVerified email at eurofins.com
- Joseph CherianAssociate Director, Medicinal Chemistry, Experimental Drug Development CentreVerified email at eddc.sg
- Stefan N. ConstantinescuProfesseur, Université catholique de Louvain- de Duve Institute, Member, Ludwig Institute for Cancer ResearchVerified email at bru.licr.org
Follow
Vishal Pendharkar
Other namesPendharkar V, VV Pendharkar, Vishal Vikas Pendharkar
Experimental Drug Development Centre (EDDC)
Verified email at eddc.sg - Homepage